Chemnick | Moen | Greenstreet

Medical Malpractice. It's All We Do. 206-443-8600

The CMG Voice

Should the US consider an “opt out” system for organ donation?

Posted Monday, March 5, 2018 by Tyler Goldberg-Hoss

Typically in the United States, the idea of organ donation occurs at some point when you interact with your state’s Department of Licensing. If you agree (opt in) to organ donation, you have a little red heart on your driver’s license.

Unfortunately, there appears to be a long-standing problem of too few organ donations for the people who need them. Recently, one count estimated the number of people in the US waiting for organ transplants at over 115,000. Regularly, such people waiting for a life saving transplant die before getting one.

Although some folks have argued for allowing for the buying and selling of organs, it is expressly against the law in the US – you can get 5 years in jail for doing so. So without a market place for organ procurement, and without enough donors to meet supply (and with the number of available donors likely to shrink in the coming decades after driverless car technology is perfected, and there are far fewer vehicular fatalities to produce viable organ donations), some countries have decided to change “opt in” systems to “opt out” systems.

Simply put, with “opt in” systems the default is that you are not an organ donor – you must affirmatively decide to be a donor. But with “opt out” systems, the default is you are an organ donor, and you must affirmatively opt out.

Currently there are over two dozen European countries with some form of an “opt out” system. Recently a couple of states introduced such legislation, but neither became law.

The system – particularly in a country such as the United States which very much values a person’s autonomy and freedom (“Don’t Tread On Me”) – many can be persuaded by the argument that an “opt out” system is allowing the government too much control over a person’s body.

But in the context of so many people dying waiting for transplants, perhaps it is time to consider a new strategy.

Permalink to this entry

JAMA releases guidelines for what doctors should know about weight loss supplements.

Posted Thursday, March 1, 2018 by Tyler Goldberg-Hoss

If you have recently visited your local pharmacy, you may have come across the shelf (or shelves, or aisle, or aisles) of supplements geared at weight loss. There are so many different supplements – promising to do many different things – that it can be difficult for a physician to counsel his or her patient about using them. And there are so many people using these supplements – by one count more than half of adult Americans have used one such product.

The Journal of the American Medical Association (JAMA) recently set out guidelines for doctors regarding their patients’ use of vitamin and mineral supplements. Although the guidelines do not attempt to analyze the merits of using any particular supplement, they do group each supplement by category, and within each category define the possible issues associated with taking the supplement.

This guidance appears to be a useful tool for clinicians in addressing this with their patients, as it gathers in one place the recommendations from different sources in one convenient location.

If you have any questions yourself about what the guidelines say about how such supplements may affect you, you can read here:

Vitamin and Mineral Supplements - What Clinicians Need to Know

Permalink to this entry

How will we address the health of our aging population? Look into the future by looking at Japan.

Posted Monday, February 26, 2018 by Tyler Goldberg-Hoss

A country is defined as “super aging” if more than 20 percent of its population is 65 or older. While the United States is not there yet, it is expected that we will be in another 40 or so years.

Given the current state of our health care system, how might we begin to address the increased burdens on it as we age? We might learn a thing or two from how Japan is doing it, and in particular how it is experimenting with technology and the well being of its elderly citizens.

The Japanese government has invested millions in this research. In one area, a bot named Palro helps to keep Japanese seniors engaged and happy, as a dancer, exercise instructor or performer. Japan is also experimenting with Virtual Reality (VR) and how it may be used.

The future is exciting and scary, but Japan’s work in this area makes it more palatable to envision.

You can read more about this here:

Watch: Japan faces its old age with robots and virtual reality

Permalink to this entry

Recent study suggests inducing labor after 39 weeks reduces need for C section

Posted Monday, February 19, 2018 by Tyler Goldberg-Hoss

The National Institutes of Health (NIH) recently published the findings of a study it funded on the issue of inducing labor in otherwise health mothers after their 39th week of pregnancy.

Current guidelines recommend against inducing labor electively (that is, without a medical reason) before the 41st week because of the perceived increase in need for a C section.

However, the results suggest that, for healthy first time mothers, when labor is induced in the 39th week of pregnancy, the risk of cesarean delivery and preeclampsia went down, as did the need for infants to need help breathing in the first three days of life.

In the study, the differences between the induced labor group and the control group (not induced after 39 weeks) were not striking. C-sections went down 3 percent in the induced labor group, preeclampsia and gestational hypertension went down 5 percent, and the number of newborns needing respiratory support went down only 1 percent.

Still, this is a decided shift in current thinking about the management of labor. We will have to see if it catches on and changes our collective thinking on the issue.

Permalink to this entry

American Heart Association warns breast cancer survivors of increased risk for cardiovascular disease

Posted Thursday, February 15, 2018 by Tyler Goldberg-Hoss

Recently the American Heart Association published a Scientific Statement outlining the risks of cardiovascular disease in breast cancer survivors, and directing oncologists to weight the risks and benefits of those treatments in light of this increased risk.

Heart disease is the leading cause of death among women. Unfortunately, the treatment for breast cancer – especially chemotherapy – has a negative impact on cardiovascular health. Because treatment now is starting earlier for breast cancer patients (with the advent of early detection), more and more women are at risk of long term cardiac complications. And for older women diagnosed with breast cancer, the cardiovascular risks of treating it with at least certain modalities may outweigh the potential benefit.

Permalink to this entry

Chemnick | Moen | Greenstreet
115 NE 100th St #220, Seattle, WA 98125 US
47.7009300-122.3265920
Phone: 206-443-8600
Fax: 206-443-6904